Cargando…

Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice

Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamadagni, Pallavi S., Jamadagni, Shrirang B., Singh, Rajendrakumar, Gaidhani, Sudesh N., Upadhyay, Sachchidanand, Hazra, Jayram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764869/
https://www.ncbi.nlm.nih.gov/pubmed/24049417
http://dx.doi.org/10.4103/0974-8520.115449
_version_ 1782283195393245184
author Jamadagni, Pallavi S.
Jamadagni, Shrirang B.
Singh, Rajendrakumar
Gaidhani, Sudesh N.
Upadhyay, Sachchidanand
Hazra, Jayram
author_facet Jamadagni, Pallavi S.
Jamadagni, Shrirang B.
Singh, Rajendrakumar
Gaidhani, Sudesh N.
Upadhyay, Sachchidanand
Hazra, Jayram
author_sort Jamadagni, Pallavi S.
collection PubMed
description Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either sex with an average body weight of 28-30 g were equally divided into four groups (Group I, II, III, and IV). Group I served as control and was given vehicle (honey: water in 2:3 ratio) Group II, III, and IV received Trivanga Bhasma @ 7.8, 39.5,and 78 mg/kg body weight for 90 consecutive days. The effect of drug was assessed on body weight, feed and water consumption changes, hematological, and histopathological parameters. At the end of the study, all animals were sacrificed and examined for gross pathological changes. Histopathological evaluation was performed for control and high dose group. Trivanga Bhasma was found to be safe. No significant clinical signs were noted in all groups studied. No major alterations were observed during histopathological evaluation. Hence, dose rate of 78 mg/kg body weight was established as NOAEL. It is suggested to carry out a toxicity study at possible higher doses and in a different species so as to establish target organ of toxicity.
format Online
Article
Text
id pubmed-3764869
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37648692013-09-18 Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice Jamadagni, Pallavi S. Jamadagni, Shrirang B. Singh, Rajendrakumar Gaidhani, Sudesh N. Upadhyay, Sachchidanand Hazra, Jayram Ayu Pharmacological Study Trivanga Bhasma, a metallic preparation containing Bhasmas of Naga (lead), Vanga (tin) and Yashada (zinc), was studied for repeated dose toxicity in Swiss albino mice to estimate No Observed Effect Level (NOEL) or No Observed Adverse Effect Level (NOAEL). A total of 80 Swiss albino mice of either sex with an average body weight of 28-30 g were equally divided into four groups (Group I, II, III, and IV). Group I served as control and was given vehicle (honey: water in 2:3 ratio) Group II, III, and IV received Trivanga Bhasma @ 7.8, 39.5,and 78 mg/kg body weight for 90 consecutive days. The effect of drug was assessed on body weight, feed and water consumption changes, hematological, and histopathological parameters. At the end of the study, all animals were sacrificed and examined for gross pathological changes. Histopathological evaluation was performed for control and high dose group. Trivanga Bhasma was found to be safe. No significant clinical signs were noted in all groups studied. No major alterations were observed during histopathological evaluation. Hence, dose rate of 78 mg/kg body weight was established as NOAEL. It is suggested to carry out a toxicity study at possible higher doses and in a different species so as to establish target organ of toxicity. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3764869/ /pubmed/24049417 http://dx.doi.org/10.4103/0974-8520.115449 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacological Study
Jamadagni, Pallavi S.
Jamadagni, Shrirang B.
Singh, Rajendrakumar
Gaidhani, Sudesh N.
Upadhyay, Sachchidanand
Hazra, Jayram
Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title_full Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title_fullStr Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title_full_unstemmed Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title_short Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice
title_sort repeated dose oral toxicity of trivanga bhasma in swiss albino mice
topic Pharmacological Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764869/
https://www.ncbi.nlm.nih.gov/pubmed/24049417
http://dx.doi.org/10.4103/0974-8520.115449
work_keys_str_mv AT jamadagnipallavis repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice
AT jamadagnishrirangb repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice
AT singhrajendrakumar repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice
AT gaidhanisudeshn repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice
AT upadhyaysachchidanand repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice
AT hazrajayram repeateddoseoraltoxicityoftrivangabhasmainswissalbinomice